Crimean-Congo hemorrhagic fever: An overview

Virologica Sinica

Volumn 28, Issue 4, 2013, Pages 193-201

  Öncü, Serkan ^a  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

Crimean Congo Hemorrhagic Fever; Diagnosis; Epidemiology; Pathogenesis; Prevention; Transmission; Treatment

Indexed keywords

RIBAVIRIN; RNA POLYMERASE;

AFRICA; ANTIBODY DETECTION; ASIA; CLINICAL FEATURE; CRIMEAN CONGO HEMORRHAGIC FEVER; DIFFERENTIAL DIAGNOSIS; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPE; GEOGRAPHIC DISTRIBUTION; HEMOSTASIS; HUMAN; IMMUNOFLUORESCENCE TEST; LABORATORY TEST; LIVESTOCK; MORTALITY; NAIRO VIRUS; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROGNOSIS; PUBLIC HEALTH; REVIEW; SEROLOGY; VIRUS INFECTION;

AFRICA; ANIMALS; ANTIVIRAL AGENTS; ASIA; COMMUNICABLE DISEASE CONTROL; EUROPE; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; RIBAVIRIN; TICKS; ZOONOSES;

EID: 84881449391     PISSN: 16740769     EISSN: 1995820X     Source Type: Journal    
DOI: 10.1007/s12250-013-3327-4     Document Type: Review

References (72)

1. Anagnostou V, and Papa A. 2009. Evolution of Crimean-Congo Hemorrhagic Fever virus. Infect Genet Evol, 9: 948-954.
2. Appannanavar S B, and Mishra B. 2011. An update on crimean congo hemorrhagic Fever. J Glob Infect Dis, 3: 285-292.
3. Ascioglu S, Leblebicioglu H, Vahaboglu H, and Chan K A. 2011. Ribavirin for patients with Crimean-Congo haemorrhagic fever: a systematic review and meta-analysis. J Antimicrob Chemother, 66: 1215-1222.
4. Atkinson B, Chamberlain J, Logue C H, Cook N, Bruce C, Dowall S D, and Hewson R. 2012. Development of a real-time rt-PCR assay for the detection of crimean-congo hemorrhagic Fever virus. Vector Borne Zoonotic Dis, 12: 786-793.
5. Bajpai S, and Nadkar M Y. 2011. Crimean Congo hemorrhagic fever: requires vigilance and not panic. J Assoc Physicians India, 59: 164-167.
6. Bakir M, Ugurlu M, Dokuzoguz B, Bodur H, Tasyaran M A, and Vahaboglu H. 2005. Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures. J Med Microbiol, 54: 385-389.
7. Bakir M, Engin A, Gozel M G, Elaldi N, Kilickap S, and Cinar Z. 2012. A new perspective to determine the severity of cases with Crimean-Congo hemorrhagic fever. J Vector Borne Dis, 49: 105-110.
8. Bangash S A, and Khan E A. 2003. Treatment and prophylaxis with ribavirin for Crimean-Congo Hemorrhagic Fever - is it effective? J Pak Med Assoc, 53: 39-41.
9. Bente D A, Alimonti J B, Shieh W J, Camus G, Stroher U, Zaki S, and Jones S M. 2010. Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model. J Virol, 84: 11089-11100.
10. Bodur H, Akinci E, Ascioglu S, Onguru P, and Uyar Y. 2012. Subclinical infections with Crimean-Congo hemorrhagic fever virus, Turkey. Emerg Infect Dis, 18: 640-642.
11. Bodur H, Akinci E, Onguru P, Uyar Y, Basturk B, Gozel M G, and Kayaaslan B U. 2010. Evidence of vascular endothelial damage in Crimean-Congo hemorrhagic fever. Int J Infect Dis, 14: e704-707.
12. Bodur H, Erbay A, Akinci E, Onguru P, Bayazit N, Eren S S, and Kubar A. 2011. Effect of oral ribavirin treatment on the viral load and disease progression in Crimean-Congo hemorrhagic fever. Int J Infect Dis, 15: e44-47.
13. Burt F J, Leman P A, Abbott J C, and Swanepoel R. 1994. Serodiagnosis of Crimean-Congo haemorrhagic fever. Epidemiol Infect, 113: 551-562.
14. Cevik M A, Erbay A, Bodur H, Eren S S, Akinci E, Sener K, Onguru P, and Kubar A. 2007. Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever. Clin Infect Dis, 45: e96-100.
15. Cherenov I V, Galimzianov K M, Sologub T V, Romantsov M G, Lokteva O M, and Kovalenko A L. 2012. Efficacy of antiviral agents in the treatment of Crimean hemorrhagic fever. Klin Med (Mosk), 90: 59-62.
16. Chinikar S, Ghiasi S M, Hewson R, Moradi M, and Haeri A. 2010. Crimean-Congo hemorrhagic fever in Iran and neighboring countries. J Clin Virol, 47: 110-114.
17. Deyde V M, Khristova M L, Rollin P E, Ksiazek T G, and Nichol S T. 2006. Crimean-Congo hemorrhagic fever virus genomics and global diversity. J Virol, 80: 8834-8842.
18. Drosten C, Gottig S, Schilling S, Asper M, Panning M, Schmitz H, and Gunther S. 2002. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J Clin Microbiol, 40: 2323-2330.
19. Duh D, Nichol S T, Khristova M L, Saksida A, Hafner-Bratkovic I, Petrovec M, Dedushaj I, Ahmeti S, and Avsic-Zupanc T. 2008. The complete genome sequence of a Crimean-Congo hemorrhagic fever virus isolated from an endemic region in Kosovo. Virol J, 5: 7.
20. Duygu F, Kaya T, and Baysan P. 2012. Re-evaluation of 400 crimean-congo hemorrhagic Fever cases in an endemic area: is ribavirin treatment suitable? Vector Borne Zoonotic Dis, 12: 812-816.
21. Elaldi N, Bodur H, Ascioglu S, Celikbas A, Ozkurt Z, Vahaboglu H, Leblebicioglu H, Yilmaz N, Engin A, Sencan M, Aydin K, Dokmetas I, Cevik M A, Dokuzoguz B, Tasyaran M A, Ozturk R, Bakir M, and Uzun R. 2009. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey. J Infect, 58: 238-244.
22. Erduran E, and Cakir M. 2010. Reactive hemophagocytic lymphohistiocytosis and Crimean-Congo hemorrhagic fever. Int J Infect Dis, 14Suppl 3: e349; author reply e350.
23. Ergonul O. 2006. Crimean-Congo haemorrhagic fever. Lancet Infect Dis, 6: 203-214.
24. Ergonul O. 2008. Treatment of Crimean-Congo hemorrhagic fever. Antiviral Res, 78: 125-131.
25. Ergonul O. 2012. Crimean-Congo hemorrhagic fever virus: new outbreaks, new discoveries. Curr Opin Virol, 2: 215-220.
26. Ergonul O, Tuncbilek S, Baykam N, Celikbas A, and Dokuzoguz B. 2006. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J Infect Dis, 193: 941-944.
27. Ergonul O, Celikbas A, Dokuzoguz B, Eren S, Baykam N, and Esener H. 2004. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. Clin Infect Dis, 39: 284-287.
28. Ertugrul B, Kirdar S, Ersoy O S, Ture M, Erol N, Ozturk B, and Sakarya S. 2012. The seroprevalence of Crimean-Congo haemorrhagic fever among inhabitants living in the endemic regions of Western Anatolia. Scand J Infect Dis, 44: 276-281.
29. Ertugrul B, Uyar Y, Yavas K, Turan C, Oncu S, Saylak O, Carhan A, Ozturk B, Erol N, and Sakarya S. 2009. An outbreak of Crimean-Congo hemorrhagic fever in western Anatolia, Turkey. Int J Infect Dis, 13: e431-436.
30. Fisher-Hoch S P, Khan J A, Rehman S, Mirza S, Khurshid M, and McCormick J B. 1995. Crimean Congo-haemorrhagic fever treated with oral ribavirin. Lancet, 346: 472-475.
31. Geisbert T W, and Jahrling P B. 2004. Exotic emerging viral diseases: progress and challenges. Nat Med, 10: S110-121.
32. Hewson R, Chamberlain J, Mioulet V, Lloyd G, Jamil B, Hasan R, Gmyl A, Gmyl L, Smirnova S E, Lukashev A, Karganova G, and Clegg C. 2004. Crimean-Congo haemorrhagic fever virus: sequence analysis of the small RNA segments from a collection of viruses world wide. Virus Res, 102: 185-189.
33. Heyman P, Cochez C, Hofhuis A, van der Giessen J, Sprong H, Porter S R, Losson B, Saegerman C, Donoso-Mantke O, Niedrig M, and Papa A. 2010. A clear and present danger: tick-borne diseases in Europe. Expert Rev Anti Infect Ther, 8: 33-50.
34. Humolli I, Dedushaj I, Zupanac T A, and Mucaj S. 2010. Epidemiological, serological and herd immunity of Crimean-Congo haemorrhagic fever in Kosovo. Med Arh, 64: 91-93.
35. Ibrahim S M, Aitichou M, Hardick J, Blow J, O'Guinn M L, and Schmaljohn C. 2011. Detection of Crimean-Congo hemorrhagic fever, Hanta, and sandfly fever viruses by real-time RT-PCR. Methods Mol Biol, 665: 357-368.
36. Izadi S, and Salehi M. 2009. Evaluation of the efficacy of ribavirin therapy on survival of Crimean-Congo hemorrhagic fever patients: a case-control study. Jpn J Infect Dis, 62: 11-15.
37. Jameson L J, Morgan P J, Medlock J M, Watola G, and Vaux A G. 2012. Importation of Hyalomma marginatum, vector of Crimean-Congo haemorrhagic fever virus, into the United Kingdom by migratory birds. Ticks Tick Borne Dis, 3: 95-99.
38. Kebede S, Duales S, Yokouide A, and Alemu W. 2010. Trends of major disease outbreaks in the African region, 2003-2007. East Afr J Public Health, 7: 20-29.
39. Keshtkar-Jahromi M, Kuhn J H, Christova I, Bradfute S B, Jahrling P B, and Bavari S. 2011. Crimean-Congo hemorrhagic fever: current and future prospects of vaccines and therapies. Antiviral Res, 90: 85-92.
40. Koksal I, Yilmaz G, Aksoy F, Aydin H, Yavuz I, Iskender S, Akcay K, Erensoy S, Caylan R, and Aydin K. 2010. The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey. J Clin Virol, 47: 65-68.
41. Kubar A, Haciomeroglu M, Ozkul A, Bagriacik U, Akinci E, Sener K, and Bodur H. 2011. Prompt administration of Crimean-Congo hemorrhagic fever (CCHF) virus hyperimmunoglobulin in patients diagnosed with CCHF and viral load monitorization by reverse transcriptase-PCR. Jpn J Infect Dis, 64: 439-443.
42. Leblebicioglu H. 2010. Crimean-Congo haemorrhagic fever in Eurasia. Int J Antimicrob Agents, 36Suppl 1: S43-46.
43. Leblebicioglu H, Bodur H, Dokuzoguz B, Elaldi N, Guner R, Koksal I, Kurt H, and Senturk G C. 2012. Case management and supportive treatment for patients with crimean-congo hemorrhagic Fever. Vector Borne Zoonotic Dis, 12: 805-811.
44. Mardani M, and Keshtkar-Jahromi M. 2007. Crimean-Congo hemorrhagic fever. Arch Iran Med, 10: 204-214.
45. Mardani M, Rahnavardi M, Rajaeinejad M, Naini K H, Chinikar S, Pourmalek F, Rostami M, and Shahri M H. 2007. Crimean-Congo hemorrhagic fever among health care workers in Iran: a seroprevalence study in two endemic regions. Am J Trop Med Hyg, 76: 443-445.
46. Marty A M, Jahrling P B, and Geisbert T W. 2006. Viral hemorrhagic fevers. Clin Lab Med, 26: 345-386, viii.
47. Mofleh J, and Ahmad Z. 2012. Crimean-Congo haemorrhagic fever outbreak investigation in the Western Region of Afghanistan in 2008. East Mediterr Health J, 18: 522-526.
48. Mourya D T, Yadav P D, Shete A M, Gurav Y K, Raut C G, Jadi R S, Pawar S D, Nichol S T, and Mishra A C. 2012. Detection, isolation and confirmation of Crimean-Congo hemorrhagic fever virus in human, ticks and animals in Ahmadabad, India, 2010-2011. PLoS Negl Trop Dis, 6: e1653.
49. Ozkurt Z, Kiki I, Erol S, Erdem F, Yilmaz N, Parlak M, Gundogdu M, and Tasyaran M A. 2006. Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. J Infect, 52: 207-215.
50. Ozturk B, Tutuncu E, Kuscu F, Gurbuz Y, Sencan I, and Tuzun H. 2012. Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: new suggestions. Int J Infect Dis, 16: e89-93.
51. Papa A, Papadimitriou E, and Christova I. 2011. The Bulgarian vaccine Crimean-Congo haemorrhagic fever virus strain. Scand J Infect Dis, 43: 225-229.
52. Papa A, Bino S, Velo E, Harxhi A, Kota M, and Antoniadis A. 2006. Cytokine levels in Crimean-Congo hemorrhagic fever. J Clin Virol, 36: 272-276.
53. Purnak T, Selvi N A, and Altundag K. 2007. Global warming may increase the incidence and geographic range of Crimean-Congo Hemorrhagic Fever. Med Hypotheses, 68: 924-925.
54. Putilina N G, Azarian A R, Trusova I N, Mal'kov P M, Grishanova A P, Kovtunov A I, Shendo G L, Dzharkenov A F, Arshba T E, Larichev V F, and Butenko A M. 2011. Use of RT-PCR and enzyme immunoassays for the specific diagnosis of Crimean hemorrhagic fever. Vopr Virusol, 56: 34-38.
55. Saijo M, Tang Q, Shimayi B, Han L, Zhang Y, Asiguma M, Tianshu D, Maeda A, Kurane I, and Morikawa S. 2004. Possible horizontal transmission of crimean-congo hemorrhagic Fever virus from a mother to her child. Jpn J Infect Dis, 57: 55-57.
56. Saijo M, Tang Q, Shimayi B, Han L, Zhang Y, Asiguma M, Tianshu D, Maeda A, Kurane I, and Morikawa S. 2005. Antigen-capture enzyme-linked immunosorbent assay for the diagnosis of crimean-congo hemorrhagic fever using a novel monoclonal antibody. J Med Virol, 77: 83-88.
57. Sanchez-Seco M P, and Navarro J M. 2005. Infections due to Toscana virus, West Nile virus, and other arboviruses of interest in Europe. Enferm Infecc Microbiol Clin, 23: 560-568.
58. Sharifi-Mood B, Metanat M, Ghorbani-Vaghei A, Fayyaz-Jahani F, and Akrami E. 2009. The outcome of patients with Crimean-Congo hemorrhagic fever in Zahedan, southeast of Iran: a comparative study. Arch Iran Med, 12: 151-153.
59. Shepherd A J, Swanepoel R, Leman P A, and Shepherd S P. 1986. Comparison of methods for isolation and titration of Crimean-Congo hemorrhagic fever virus. J Clin Microbiol, 24: 654-656.
60. Soares-Weiser K, Thomas S, Thomson G, and Garner P. 2010. Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis. BMC Infect Dis, 10: 207.
61. Tasdelen Fisgin N, Ergonul O, Doganci L, and Tulek N. 2009. The role of ribavirin in the therapy of Crimean-Congo hemorrhagic fever: early use is promising. Eur J Clin Microbiol Infect Dis, 28: 929-933.
62. Tekin S, Bursali A, Mutluay N, Keskin A, and Dundar E. 2012. Crimean-Congo hemorrhagic fever virus in various ixodid tick species from a highly endemic area. Vet Parasitol, 186: 546-552.
63. Tezer H, Sucakli I A, Sayli T R, Celikel E, Yakut I, Kara A, Tunc B, and Ergonul O. 2010. Crimean-Congo hemorrhagic fever in children. J Clin Virol, 48: 184-186.
64. Tignor G H, and Hanham C A. 1993. Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infection. Antiviral Res, 22: 309-325.
65. Turkdogan K A, Zorlu A, Engin A, Guven F M, Polat M M, Turgut O O, and Yilmaz M B. 2012. C-type natriuretic peptide is associated with the severity of Crimean-Congo hemorrhagic fever. Int J Infect Dis, 16: e616-620.
66. Vanhomwegen J, Alves M J, Zupanc T A, Bino S, Chinikar S, Karlberg H, Korukluoglu G, Korva M, Mardani M, Mirazimi A, Mousavi M, Papa A, Saksida A, Sharifi-Mood B, Sidira P, Tsergouli K, Wolfel R, Zeller H, and Dubois P. 2012. Diagnostic assays for crimean-congo hemorrhagic fever. Emerg Infect Dis, 18: 1958-1965.
67. Vassilenko S M, Vassilev T L, Bozadjiev L G, Bineva I L, and Kazarov G Z. 1990. Specific intravenous immunoglobulin for Crimean-Congo haemorrhagic fever. Lancet, 335: 791-792.
68. Watts D M, Ussery M A, Nash D, and Peters C J. 1989. Inhibition of Crimean-Congo hemorrhagic fever viral infectivity yields in vitro by ribavirin. Am J Trop Med Hyg, 41: 581-585.
69. Whitehouse C A. 2004. Crimean-Congo hemorrhagic fever. Antiviral Res, 64: 145-160.
70. Xia H, Li P, Yang J, Pan L, Zhao J, Wang Z, Li Y, Zhou H, Dong Y, Guo S, Tang S, Zhang Z, Fan Z, Hu Z, Kou Z, and Li T. 2011. Epidemiological survey of Crimean-Congo hemorrhagic fever virus in Yunnan, China, 2008. Int J Infect Dis, 15: e459-463.
71. Yen Y C, Kong L X, Lee L, Zhang Y Q, Li F, Cai B J, and Gao S Y. 1985. Characteristics of Crimean-Congo hemorrhagic fever virus (Xinjiang strain) in China. Am J Trop Med Hyg, 34: 1179-1182.
72. Zeller H. 2007. Laboratory Diagnosis of Crimean-Congo Hemorrhagic Fever, p. 233-243. In Ergonul O and Whitehouse C A (ed.), Crimean-Congo Hemorrhagic Fever: A Global Perspective. Springer, Dordrecht.